JP2022077034A - Hibiscus hamabo extract, cosmetics containing the hibiscus hamabo extract and functional food - Google Patents

Hibiscus hamabo extract, cosmetics containing the hibiscus hamabo extract and functional food Download PDF

Info

Publication number
JP2022077034A
JP2022077034A JP2021183685A JP2021183685A JP2022077034A JP 2022077034 A JP2022077034 A JP 2022077034A JP 2021183685 A JP2021183685 A JP 2021183685A JP 2021183685 A JP2021183685 A JP 2021183685A JP 2022077034 A JP2022077034 A JP 2022077034A
Authority
JP
Japan
Prior art keywords
extract
component
hamabou
aqueous
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021183685A
Other languages
Japanese (ja)
Other versions
JP7388748B2 (en
Inventor
誠 出島
Makoto Dejima
邦義 清水
Kuniyoshi Shimizu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DIGIMA KK
Original Assignee
DIGIMA KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DIGIMA KK filed Critical DIGIMA KK
Publication of JP2022077034A publication Critical patent/JP2022077034A/en
Application granted granted Critical
Publication of JP7388748B2 publication Critical patent/JP7388748B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seasonings (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

To reduce aging troubles: rise in a blood glucose level, excessive ingestion of lipid, pigmentation of a skin and lost resilience of the skin, with a single plant-derived extract.SOLUTION: A Hibiscus hamabo extract comprises a component group showing solubility in an aqueous solvent made chiefly of water or a nonaqueous specific solvent composed of a liquid mixture of one or more of dimethyl sulfoxide, ethanol, methanol, and hexane, which at least comprises a hyperglycemia inhibitory component, a fat absorption inhibitory component, a melanogenesis inhibitory component and a collagen production promoting component. In some embodiments, the component group comprises a component group showing solubility in the aqueous solvent and further comprises a hypertension inhibitory component.SELECTED DRAWING: Figure 1

Description

本発明は、ハマボウ抽出物、同ハマボウ抽出物を含有する化粧料及び機能性食品に関する。 The present invention relates to a Hibiscus hamabo extract, a cosmetic containing the Hibiscus hamabo extract, and a functional food.

従来、日々の生活を健康に、また美しく送るために、医薬品や化粧料、機能性食品など様々な製品が提供されている。 Conventionally, various products such as medicines, cosmetics, and functional foods have been provided in order to lead a healthy and beautiful daily life.

特に近年は、消費者の健康志向や美容志向の高まりを受け、各メーカーは製品の原料となる新たな素材を模索している。 Especially in recent years, in response to the growing health and beauty consciousness of consumers, each manufacturer is searching for new materials that can be used as raw materials for products.

中でも植物資源は、新たな素材の探索対象として開発の余地が未だ十分に残されており、健康や美容の側面で今後も我々の生活に大きく寄与するものと考えられる(例えば、特許文献1参照。)。 Above all, plant resources still have ample room for development as a search target for new materials, and are considered to continue to contribute significantly to our lives in terms of health and beauty (see, for example, Patent Document 1). .).

特開2019-201594号公報Japanese Unexamined Patent Publication No. 2019-201594

ところで、ヒトは年齢を重ねると、体調に様々な変化が現れる。中でも血糖値の慢性的な上昇は糖尿病を招き、神経障害や網膜症などの合併症を引き起こすこととなるため、日々の食生活の中で節制を心がけるのが望ましい。 By the way, as humans get older, various changes appear in their physical condition. Above all, chronic increase in blood glucose level leads to diabetes and causes complications such as neuropathy and retinopathy, so it is desirable to keep in mind in daily eating habits.

また、血中脂質が高めになると脂質異常症を招き、虚血性心疾患や脳梗塞などを引き起こす恐れが高まる。 In addition, when blood lipids are high, it causes dyslipidemia, which increases the risk of causing ischemic heart disease and cerebral infarction.

また、年齢の高まりと共に顔や手の肌質にも変化が現れる。例えば、色素の沈着が起こりやすく、些細な肌のトラブルがシミの原因となったり、また、肌の弾力(張り)もなくなってくる。 In addition, as the age increases, the skin quality of the face and hands also changes. For example, pigmentation is likely to occur, minor skin problems may cause blemishes, and skin elasticity (tension) may be lost.

そこで、これらの問題に対処するため、これまでに様々な植物由来の素材やエキス(以下、単に植物素材ともいう。)が提案されている。 Therefore, in order to deal with these problems, various plant-derived materials and extracts (hereinafter, also simply referred to as plant materials) have been proposed so far.

しかし、これまでに知られている植物素材は、血糖や血中脂質、色素沈着や肌の張りの改善など、それぞれの機能を実現するためには、それぞれの目的に応じた植物素材を添加する必要があった。 However, for the plant materials known so far, in order to realize each function such as blood sugar, blood lipids, pigmentation and improvement of skin tension, plant materials suitable for each purpose are added. I needed it.

本発明は、斯かる事情に鑑みてなされたものであって、加齢と共に気になることが多い血糖値や脂質の摂取、また肌の色素沈着や弾力の改善を単一の植物由来の抽出物にて実現すべく完成されたものである。 The present invention has been made in view of such circumstances, and extracts blood glucose levels and lipids, which are often anxious with aging, as well as skin pigmentation and improvement of elasticity from a single plant. It was completed to be realized by things.

上記従来の課題を解決するために、本発明では、水を主成分とする水系溶媒又はジメチルスルホキシド、エタノール、メタノール、ヘキサンから選ばれるいずれか1つ若しくはいずれか2つ以上の混合液からなる非水系特定溶媒に対して溶解性を示す成分群よりなり、血糖値上昇抑制成分と脂肪吸収抑制成分とメラニン生成抑制成分とコラーゲン産生促進成分とを少なくとも含有するハマボウ抽出物とした。 In order to solve the above-mentioned conventional problems, in the present invention, the present invention comprises a water-based solvent containing water as a main component or a non-mixed solution consisting of any one or a mixture of two or more selected from dimethylsulfoxide, ethanol, methanol and hexane. A Hamabou extract was prepared by comprising a group of components exhibiting solubility in a specific aqueous solvent and containing at least a component for suppressing increase in blood glucose level, a component for suppressing fat absorption, a component for suppressing melanin production, and a component for promoting collagen production.

また本発明に係るハマボウ抽出物は、前記成分群は水系溶媒に溶解性を示す成分群よりなり、血圧上昇抑制成分を更に含有することにも特徴を有する。 Further, the Hibiscus hamabo extract according to the present invention is also characterized in that the component group comprises a component group exhibiting solubility in an aqueous solvent and further contains a component for suppressing an increase in blood pressure.

また本発明では、上述のハマボウ抽出物を含有する化粧料や機能性食品についても提供する。 The present invention also provides cosmetics and functional foods containing the above-mentioned Hibiscus hamabo extract.

また本発明に係る機能性食品は、Lactobacillus属、Lactococcus属、Enterococcus属、Bifidobacterium属から選ばれる少なくともいずれか1つの属の乳酸菌体が、前記ハマボウ抽出物の乾燥物0.1gあたり1.0×105個以上添加されていることにも特徴を有する。 In addition, the functional food according to the present invention contains 1.0 x 10 5 lactic acid bacteria cells of at least one genus selected from the genus Lactobacillus, Lactococcus, Enterococcus, and Bifidobacterium per 0.1 g of the dried product of the Hamabou extract. It is also characteristic that it is added as described above.

また本発明では、水を主成分とする水系溶媒又はジメチルスルホキシド、エタノール、メタノール、ヘキサンから選ばれるいずれか1つ若しくはいずれか2つ以上の混合液からなる非水系特定溶媒に対して溶解性を示す成分群よりなるハマボウ抽出物を、前記ハマボウ抽出物に由来する血糖値上昇抑制、脂肪吸収抑制、メラニン生成抑制、コラーゲン産生促進、血圧上昇抑制から選ばれる少なくともいずれか1つの事象を作用又は効果として含む目的のための機能性食品において、前記事象の発現と対応する前記ハマボウ抽出物の構成成分を保健機能成分(関与成分)とする機能性食品の原料として使用することとした。 Further, in the present invention, the solubility is made in an aqueous solvent containing water as a main component or a non-aqueous specific solvent composed of a mixture of any one or two or more selected from dimethylsulfoxide, ethanol, methanol and hexane. The Hamabou extract consisting of the indicated component group acts or has an effect on at least one event selected from the suppression of blood glucose level increase, the suppression of fat absorption, the suppression of melanin production, the promotion of collagen production, and the suppression of blood pressure increase derived from the Hamabou extract. In the functional food for the purpose of including, it was decided to use the constituent component of the Hamabou extract corresponding to the occurrence of the event as a raw material of the functional food containing the health functional component (participating component).

また本発明では、水を主成分とする水系溶媒又はジメチルスルホキシド、エタノール、メタノール、ヘキサンから選ばれるいずれか1つ若しくはいずれか2つ以上の混合液からなる非水系特定溶媒に対して溶解性を示す成分群よりなるハマボウ抽出物を、前記ハマボウ抽出物に由来するメラニン生成抑制又はコラーゲン産生促進の少なくともいずれか1つの事象を作用又は効果として含む目的のための化粧料において、前記事象の発現と対応する前記ハマボウ抽出物の構成成分を有効成分とする化粧料の原料として使用することとした。 Further, in the present invention, the solubility is made in an aqueous solvent containing water as a main component or a non-aqueous specific solvent composed of a mixture of any one or two or more selected from dimethylsulfoxide, ethanol, methanol and hexane. Expression of the above-mentioned event in a cosmetic for the purpose of comprising at least one event of suppressing melanin production or promoting collagen production derived from the Hamabou extract as an action or effect of the Hamabou extract consisting of the indicated component group. It was decided to use it as a raw material for cosmetics containing the constituent component of the Hamabou extract corresponding to the above as an active ingredient.

また本発明では、ハマボウ抽出物の渋みと甘みの強弱を相互に官能的に逆転させるために、乳酸菌体をハマボウ抽出物用の呈味改善用添加剤として使用した。 Further, in the present invention, in order to sensually reverse the astringency and sweetness of the Hibiscus hamabo extract, lactic acid bacteria cells were used as an additive for improving the taste of the Hibiscus hamabo extract.

本発明によれば、水を主成分とする水系溶媒又はジメチルスルホキシド、エタノール、メタノール、ヘキサンから選ばれるいずれか1つ若しくはいずれか2つ以上の混合液からなる非水系特定溶媒に対して溶解性を示す成分群よりなり、血糖値上昇抑制成分と脂肪吸収抑制成分とメラニン生成抑制成分とコラーゲン産生促進成分とを少なくとも含有するハマボウ抽出物としたため、加齢と共に気になることが多い血糖値や脂質の摂取、また肌の色素沈着や弾力の改善を、ハマボウという単一の植物由来の抽出物にて実現することができる。 According to the present invention, it is soluble in an aqueous solvent containing water as a main component or a non-aqueous specific solvent consisting of one or a mixture of two or more selected from dimethylsulfoxide, ethanol, methanol and hexane. The Hamabou extract contains at least a blood glucose level increase inhibitory component, a fat absorption inhibitory component, a melanin production inhibitory component, and a collagen production promoting component. Ingestion of lipids and improvement of skin pigmentation and elasticity can be achieved with a single plant-derived extract called Hamabou.

また、前記成分群は水系溶媒に溶解性を示す成分群よりなり、血圧上昇抑制成分を更に含有することとすれば、更に血圧についてもハマボウという単一の植物由来の抽出物にて実現することができる。 Further, the component group is composed of a component group exhibiting solubility in an aqueous solvent, and if it further contains a component for suppressing an increase in blood pressure, the blood pressure can be further realized by a single plant-derived extract called Hamabou. Can be done.

また、これらハマボウ抽出物を化粧料や機能性食品に含ませれば、これらの使用により、上述の血糖値や脂質、肌の色素沈着の抑制や弾力の改善を図ることができる。 In addition, if these Hibiscus hamabo extracts are included in cosmetics and functional foods, the use of these extracts can suppress the above-mentioned blood glucose level, lipids, and skin pigmentation and improve elasticity.

また、ハマボウ抽出物に乳酸菌体を添加すれば、呈味改善が図られた機能性食品を提供することができる。 Further, by adding lactic acid bacteria cells to the Hibiscus hamabo extract, it is possible to provide a functional food with improved taste.

α-グルコシダーゼ阻害活性を示す説明図である。It is explanatory drawing which shows the α-glucosidase inhibitory activity. リパーゼ生成阻害活性を示す説明図である。It is explanatory drawing which shows the lipase production inhibitory activity. ACE阻害活性率を示す説明図である。It is explanatory drawing which shows the ACE inhibitory activity rate. 細胞あたりのメラニン産生率を示す説明図である。It is explanatory drawing which shows the melanin production rate per cell. コラーゲン産生比を示す説明図である。It is explanatory drawing which shows the collagen production ratio.

本発明は、ハマボウ抽出物に関するものであり、特に、所定の溶媒にて抽出された成分を含有する点で特徴的なハマボウ抽出物である。 The present invention relates to a Hibiscus hamabo extract, and is particularly characteristic of a Hibiscus hamabo extract in that it contains a component extracted with a predetermined solvent.

本明細書においてハマボウは、学名がHibiscus hamaboとして知られる植物を意味する。なお、オオハマボウ(学名:Talipariti tiliaceum)は似たような名前ではあるが、本発明の対象であるハマボウとは全く異なる植物である点に留意されたい。ハマボウは樹高が1~5mほどの落葉低木であるが、オオハマボウは樹高が4~12mにもなる常緑の小高木であり、その他形質的に異なる点が多い相互に遺伝的距離のある植物である。 As used herein, Hamabou means a plant whose scientific name is known as Hibiscus hamabo. It should be noted that although Hibiscus tiliaceus (scientific name: Talipariti tiliaceum) has a similar name, it is a completely different plant from the Hibiscus tiliaceae, which is the subject of the present invention. Hibiscus tiliaceus is a deciduous shrub with a height of about 1 to 5 m, while Hibiscus tiliaceus is an evergreen small tree with a height of 4 to 12 m. ..

本実施形態に係るハマボウ抽出物は、水系溶媒又は特定の非水系溶媒(非水系特定溶媒ともいう)にて抽出された抽出物である。 The Hamabou extract according to the present embodiment is an extract extracted with an aqueous solvent or a specific non-aqueous solvent (also referred to as a non-aqueous specific solvent).

水系溶媒は水を主成分とする溶媒であり、水そのものの他、水に相溶性を示すアルコール類や塩類などが添加されたものも水の割合が50%以上であれば本明細書の水系溶媒に該当する。 The water-based solvent is a solvent containing water as a main component, and in addition to water itself, those to which alcohols or salts showing compatibility with water are added are also water-based as described in the present specification if the ratio of water is 50% or more. Corresponds to the solvent.

非水系特定溶媒は、ジメチルスルホキシド、エタノール、メタノール、ヘキサンから選ばれるいずれか1つ若しくはいずれか2つ以上の混合液がその組成の80w/w%以上、より好ましくは90w/w%以上を占める溶媒、更に好ましくは、いずれか1つ若しくはいずれか2つ以上の混合液からなる溶媒である。 As the non-aqueous specific solvent, a mixed solution of any one or any two or more selected from dimethyl sulfoxide, ethanol, methanol and hexane occupies 80 w / w% or more, more preferably 90 w / w% or more of the composition. A solvent, more preferably a solvent consisting of any one or a mixture of any two or more.

ハマボウの抽出対象部位は特に限定されず、例えば、葉、枝、幹、種子、花、根、その他の部位、またはこれらの部位のいずれか一部又は全部の混合物を対象とすることができる。 The extraction target site of Hibiscus hamabo is not particularly limited, and for example, leaves, branches, stems, seeds, flowers, roots, other sites, or a mixture of any part or all of these sites can be targeted.

そして、本実施形態に係るハマボウ抽出物は、ハマボウの構成成分のうち上述の水系溶媒に溶解性を示す成分群(以下、水系成分群ともいう。)又は非水系特定溶媒に対して溶解性を示す成分群(以下、非水系成分群ともいう。)よりなり、いずれの場合においても、血糖値上昇抑制成分と脂肪吸収抑制成分とメラニン生成抑制成分とコラーゲン産生促進成分とを少なくとも含有している点で特徴的である。 The Hamabou extract according to the present embodiment has a solubility in the above-mentioned aqueous solvent-soluble component group (hereinafter, also referred to as an aqueous component group) or a non-aqueous specific solvent among the constituent components of Hamabou. It consists of the indicated component groups (hereinafter, also referred to as non-aqueous component groups), and in each case, it contains at least a blood glucose level increase inhibitory component, a fat absorption inhibitory component, a melanin production inhibitory component, and a collagen production promoting component. It is characteristic in terms of points.

血糖値上昇抑制成分は、例えば、水系又は非水系成分群のうちα-グルコシダーゼの活性を阻害する成分、特に、小腸上皮細胞に存在するα-グルコシダーゼのインヒビターとして機能する成分であるのが好ましい。具体的には、基質として37℃の0.1 M スクロース水溶液を100μl調製し、これに0.5 U(1Uは、30℃、30分間で1 μmolの基質をグルコースに消化できる活性単位)のα-グルコシダーゼと、終濃度が0.002、0.02、0.2、0.4 mg/mlとなる量のハマボウより抽出された水系成分群の乾燥物を水に溶かした液(以下、水抽出物溶液という。)、又は非水系成分群の乾燥物を所定の溶媒に溶かした液(以下、非水系抽出物溶液という。)を添加して37℃、30分間反応させたときの基質であるスクロースの濃度を維持または分解抑制できる場合に、当該水系又は非水系成分群には血糖値上昇抑制成分が含まれると解釈できる。 The component for suppressing the increase in blood glucose level is preferably, for example, a component that inhibits the activity of α-glucosidase in the aqueous or non-aqueous component group, particularly a component that functions as an inhibitor of α-glucosidase present in small intestinal epithelial cells. Specifically, 100 μl of a 0.1 M sucrose aqueous solution at 37 ° C was prepared as a substrate, and 0.5 U (1 U is an active unit capable of digesting 1 μmol of the substrate into glucose at 30 ° C for 30 minutes) with α-glucosidase. , A solution of a dried product of an aqueous component group extracted from sucrose with a final concentration of 0.002, 0.02, 0.2, 0.4 mg / ml in water (hereinafter referred to as a water extract solution), or a non-aqueous component. When the concentration of sucrose, which is a substrate, can be maintained or suppressed when a solution in which the dried product of the group is dissolved in a predetermined solvent (hereinafter referred to as a non-aqueous extract solution) is added and reacted at 37 ° C. for 30 minutes. In addition, it can be interpreted that the aqueous or non-aqueous component group contains a component for suppressing an increase in blood glucose level.

脂肪吸収抑制成分は、例えばリパーゼの活性を阻害する成分である。具体的には、基質として37℃の0.1 mM 4-methylumbelliferyl oleate(4-MUO)溶液を50μl調製し、これに3.75 μg(1Uは、1 mmol 100% triolein を37℃、pH 8.0、2時間で加水分解してdioleinかoleic acidに消化できる活性単位)の膵臓由来リパーゼと、終濃度が0.5、5、10 mg/mlとなる量の水系成分群の乾燥物を水(又は所定の緩衝液)に溶かした液(以下、水抽出物溶液という。)、又は非水系成分群の乾燥物を所定の溶媒に溶かした液(以下、非水系抽出物溶液という。)を添加して25℃で30分間反応させたときの基質である4-メチルウンベリフェロンの蛍光強度がポジティブコントロールとして使用したオルリスタット(終濃度0.005 mg/mL)と同程度またはそれ以下にできる場合に、当該水系又は非水系成分群には脂肪吸収抑制成分が含まれると解釈できる。 The fat absorption inhibitor is, for example, a component that inhibits the activity of lipase. Specifically, 50 μl of a 0.1 mM 4-methylumbelliferyl oleate (4-MUO) solution at 37 ° C was prepared as a substrate, and 3.75 μg (1 U was 1 mmol 100% triolein at 37 ° C, pH 8.0, 2 hours). Water (or a given buffer) of pancreatic-derived lipase (an active unit that can be hydrolyzed and digested into diolein or oleic acid) and a dried product of an aqueous component group having a final concentration of 0.5, 5, 10 mg / ml. A solution in which a solution dissolved in water (hereinafter referred to as a water extract solution) or a solution obtained by dissolving a dried product of a non-aqueous component group in a predetermined solvent (hereinafter referred to as a non-aqueous extract solution) is added and 30 ° C. If the fluorescence intensity of 4-methylumbelliferone, which is the substrate when reacted for 1 minute, can be equal to or lower than that of orlistat (final concentration 0.005 mg / mL) used as a positive control, the aqueous or non-aqueous component is concerned. It can be interpreted that the group contains a fat absorption inhibitor.

メラニン生成抑制成分は、皮膚を構成する細胞にてメラニン色素の産生を抑制することのできる成分である。具体的には、水抽出物溶液又は非水系抽出物溶液の存在下にて培養したメラノーマ細胞が産生するメラニン量と、同抽出物溶液の非存在下でのメラニン量とを405nmでの吸光度で比較し、非存在下に比してメラニン生成量が少ない場合には、水系又は非水系成分群にはメラニン生成抑制成分が含まれると解釈できる。 The melanin production inhibitory component is a component capable of suppressing the production of melanin pigment in the cells constituting the skin. Specifically, the amount of melanin produced by melanin cells cultured in the presence of an aqueous extract solution or a non-aqueous extract solution and the amount of melanin in the absence of the extract solution are measured by absorbance at 405 nm. In comparison, when the amount of melanin produced is smaller than that in the absence, it can be interpreted that the aqueous or non-aqueous component group contains a melanin production inhibitory component.

コラーゲン産生促進成分は、皮膚を構成する細胞にてコラーゲンの産生を促進することのできる成分である。具体的には、水抽出物溶液又は非水系抽出物溶液の存在下にて培養したヒト皮膚繊維芽細胞が産生するコラーゲン量と、同抽出物溶液の非存在下でのコラーゲン量とを比較し、非存在下に比してコラーゲン産生量が多い場合には、水系又は非水系成分群にはコラーゲン産生促進成分が含まれると解釈できる。 The collagen production promoting component is a component capable of promoting collagen production in the cells constituting the skin. Specifically, the amount of collagen produced by human skin fibroblasts cultured in the presence of a water extract solution or a non-aqueous extract solution is compared with the amount of collagen in the absence of the extract solution. When the amount of collagen produced is larger than that in the absence, it can be interpreted that the aqueous or non-aqueous component group contains a collagen production promoting component.

そして、このような構成を備える本実施形態に係るハマボウ抽出物によれば、加齢と共に気になることが多い血糖値や脂質の摂取、また肌の色素沈着や弾力の改善を単一の植物由来の抽出物にて実現することができる。 According to the Hamabou extract according to the present embodiment having such a structure, the intake of blood sugar level and lipid, which are often anxious with aging, and the improvement of skin pigmentation and elasticity are single plants. It can be realized with the extract of origin.

また、本実施形態に係るハマボウ抽出物では、前記成分群は水系溶媒に溶解性を示す成分群、すなわち水系成分群よりなり、血圧上昇抑制成分を更に含有することとしても良い。 Further, in the Hamabou extract according to the present embodiment, the component group comprises a component group exhibiting solubility in an aqueous solvent, that is, an aqueous component group, and may further contain a component for suppressing an increase in blood pressure.

ここで血圧上昇抑制成分は、アンジオテンシン変換酵素(ACE)の活性を阻害することのできる成分である。具体的には、3-Hydroxybutyryl-Gly-Gly-Glyより遊離した3-Hydroxybutyric acidを酵素法により検出する方法、例えば同仁化学研究所製ACE Kit-WSTを用い、水抽出物溶液の存在下でのACE活性と非存在下でのACE活性とを比較し、非存在下に比してACE活性が抑制される場合には、水系成分群には血圧上昇抑制成分が含まれると解釈できる。 Here, the blood pressure increase inhibitory component is a component capable of inhibiting the activity of angiotensin converting enzyme (ACE). Specifically, a method for detecting 3-Hydroxybutyric acid liberated from 3-Hydroxybutyryl-Gly-Gly-Gly by an enzymatic method, for example, using ACE Kit-WST manufactured by Dojin Chemical Research Institute, in the presence of a water extract solution. When the ACE activity is compared with the ACE activity in the absence of ACE, and the ACE activity is suppressed as compared with the absence, it can be interpreted that the aqueous component group contains a blood pressure increase inhibitory component.

そして、このような構成を備える本実施形態に係るハマボウ抽出物によれば、更に血圧についてもハマボウという単一の植物由来の抽出物にて実現することができる。 According to the Hamabou extract according to the present embodiment having such a configuration, blood pressure can be further realized by a single plant-derived extract called Hamabo.

また本願では、本実施形態に係るハマボウ抽出物を含有する化粧料を提供する。また本願は併せて、このような化粧料を実現する際の、化粧料におけるハマボウ抽出物の化粧料の原料としての使用を提案するものでもある。 Further, the present application provides a cosmetic containing the Hibiscus hamabo extract according to the present embodiment. The present application also proposes the use of the Hamabou extract in cosmetics as a raw material for cosmetics in realizing such cosmetics.

ここで化粧料は、一般に、清潔にする、美化する、魅力を増す、健やかに保つなどの目的で使用される効能・効果が緩和な化粧品を含むほか、所謂薬用化粧品の如き医薬部外品も含む。 Here, cosmetics generally include cosmetics with mild efficacy and effects used for the purpose of cleaning, beautifying, increasing attractiveness, keeping healthy, and also quasi-drugs such as so-called medicated cosmetics. include.

本願の化粧料は、ハマボウ抽出物に由来するメラニン生成抑制又はコラーゲン産生促進の少なくともいずれか1つの事を作用又は効果として含む目的のための化粧料である。なお、作用又は効果として含む目的とは、その化粧料にメラニン生成抑制を目的とすることやコラーゲン産生促進を目的とすることが明記されている場合、例えば薬用化粧料の如く効果効能として記載されている場合を含むのは勿論のこと、このように明記されておらずとも、肌を白くするや、肌に張りを与えるなどのように経過の一部や結果の表現が記載されているならば、それは本願の化粧料に相当する。 The cosmetic of the present application is a cosmetic for the purpose of including at least one of suppression of melanin production or promotion of collagen production derived from Hibiscus hamabo extract as an action or effect. In addition, when it is clearly stated that the purpose of the action or effect is to suppress melanin production or to promote collagen production in the cosmetic, it is described as an effect effect such as medicated cosmetics. Of course, even if it is not specified in this way, if a part of the process or an expression of the result is described, such as whitening the skin or giving tension to the skin. If so, it corresponds to the cosmetics of the present application.

化粧料に使用されるハマボウ抽出物は、前述の水系又は非水系成分群よりなる。 The Hibiscus hamabo extract used in cosmetics consists of the above-mentioned aqueous or non-aqueous component group.

また、化粧料の原料としてのハマボウ抽出物の使用は、前述のメラニン生成抑制又はコラーゲン産生促進の発現と対応するハマボウ抽出物の構成成分を有効成分とした使用である。なお、有効成分はハマボウ抽出物を構成する成分の一部でも良いし全部でも良い。すなわち、有効成分はハマボウ抽出物を構成する同定されたある成分乃至複数の成分でも良いし、ハマボウ抽出物自体が有効成分であっても良い。 In addition, the use of the Hibiscus hamabo extract as a raw material for cosmetics is the use of the constituent components of the Hibiscus hamabo extract corresponding to the above-mentioned expression of suppression of melanin production or promotion of collagen production as an active ingredient. The active ingredient may be a part or all of the constituents of the Hibiscus hamabo extract. That is, the active ingredient may be an identified component or a plurality of identified components constituting the Hibiscus hamabo extract, or the Hibiscus hamabo extract itself may be the active ingredient.

このような構成とすることにより、肌の色素沈着や弾力の改善を、ハマボウという単一の植物由来の抽出物にて実現することが可能な化粧料を提供することができる。 With such a configuration, it is possible to provide a cosmetic that can realize skin pigmentation and improvement of elasticity with a single plant-derived extract called Hibiscus hamabo.

また本願では、本実施形態に係るハマボウ抽出物を含有する機能性食品を提供する。また本願は併せて、このような機能性食品を実現する際の、機能性食品におけるハマボウ抽出物の機能性食品の原料としての使用を提案するものでもある。 Further, the present application provides a functional food containing the Hibiscus hamabo extract according to the present embodiment. The present application also proposes the use of Hamabou extract as a raw material for functional foods in functional foods when realizing such functional foods.

ここで機能性食品は、医薬品成分を含まない健康の保持増進に寄与するとされる食品全般を包含する概念であり、例えば、栄養補助食品や健康補助食品、栄養調整食品のほか、所謂サプリメントなどの一般食品であったり、特定保健用食品や栄養機能食品、機能性表示食品の如き保健機能食品も含まれる。 Here, functional food is a concept that includes all foods that do not contain pharmaceutical ingredients and are considered to contribute to the maintenance and promotion of health. It also includes general foods, foods for specified health use, foods with nutritional function, and foods with health claims such as foods with functional claims.

なお、上述した化粧料や機能性食品についての説明は、本発明の理解に供すべくこれらに相当する物品等の一例を列挙したものであり、各語句の解釈はこれら列挙された物品等に限定されるものではない。ただし、本出願人が本願を権利化するにあたり、本発明をこれら物品等に限定することを妨げない。 In addition, the above-mentioned explanation about cosmetics and functional foods is a list of examples of articles and the like corresponding thereto for the understanding of the present invention, and the interpretation of each term is limited to these listed articles and the like. It is not something that will be done. However, it does not prevent the applicant from limiting the present invention to these articles, etc. in order to acquire the rights of the present application.

本願の機能性食品は、ハマボウ抽出物に由来する血糖値上昇抑制、脂肪吸収抑制、メラニン生成抑制、コラーゲン産生促進、血圧上昇抑制の少なくともいずれか1つの事を作用又は効果として含む目的のための機能性食品である。なお、作用又は効果として含む目的については、先の化粧料の例と同様、これらの事項が効果効能として記載されている場合を含むのは勿論のこと、経過の一部や結果の表現が記載されている場合も含む。 The functional food of the present application is intended to include at least one of suppression of blood glucose level increase, fat absorption suppression, melanin production suppression, collagen production promotion, and blood pressure increase suppression derived from Hamabou extract as an action or effect. It is a functional food. As for the purpose to be included as an action or effect, as in the case of the previous cosmetics, not only the case where these matters are described as the effect and efficacy, but also a part of the progress and the expression of the result are described. Including the case where it has been done.

機能性食品に使用されるハマボウ抽出物は、前述の水系又は非水系成分群よりなる。 The Hibiscus hamabo extract used in functional foods consists of the above-mentioned aqueous or non-aqueous component group.

また、機能性食品の原料としてのハマボウ抽出物の使用は、前述の血糖値上昇抑制、脂肪吸収抑制、メラニン生成抑制、コラーゲン産生促進、血圧上昇抑制の発現と対応するハマボウ抽出物の構成成分を保健機能成分(関与成分)とした使用である。なお、保健機能成分(関与成分)はハマボウ抽出物を構成する成分の一部でも良いし全部でも良い。すなわち、保健機能成分(関与成分)はハマボウ抽出物を構成する同定されたある成分乃至複数の成分でも良いし、ハマボウ抽出物自体が有効成分であっても良い。 In addition, the use of Hamabou extract as a raw material for functional foods is a component of Hamabou extract that corresponds to the above-mentioned suppression of blood glucose level increase, fat absorption suppression, melanin production suppression, collagen production promotion, and blood pressure increase suppression. It is used as a health functional ingredient (participating ingredient). The health functional component (participating component) may be a part or all of the components constituting the Hibiscus hamabo extract. That is, the health functional component (participating component) may be an identified component or a plurality of identified components constituting the Hibiscus hamabo extract, or the Hibiscus hamabo extract itself may be the active ingredient.

このような構成とすることにより、血糖値や脂質の摂取、血圧上昇抑制、また肌の色素沈着や弾力の改善を、ハマボウという単一の植物由来の抽出物にて実現することが可能な機能性食品を提供することができる。 With such a configuration, it is possible to realize the intake of blood sugar level and lipid, suppression of blood pressure increase, and improvement of skin pigmentation and elasticity with a single plant-derived extract called Hamabou. Sex foods can be provided.

ところで、ハマボウ抽出物は、抽出溶媒が水系溶媒か非水系特定溶媒かに関わらず、口にした時に渋みと甘みを感じる。両者は異なる味覚であるものの、相対的には渋みの方はやや強く感じられ、甘みの方はやや弱く感じられる。 By the way, the Hamabou extract feels astringent and sweet when it is eaten, regardless of whether the extraction solvent is an aqueous solvent or a non-aqueous specific solvent. Although the two have different tastes, the astringent one feels a little stronger and the sweet one feels a little weaker.

このような官能的側面を有するハマボウ抽出物であるが、本発明者らはこれまで行ってきた鋭意研究により、乳酸菌体を本実施形態に係るハマボウ抽出物に添加することで、この渋みと甘みの強弱を逆転させることが可能であることを見出している。 Although the Hibiscus hamabo extract has such a sensual aspect, the present inventors have conducted diligent research so far to add lactic acid bacteria cells to the Hibiscus hamabo extract according to the present embodiment to obtain this astringency and sweetness. We have found that it is possible to reverse the strength of.

このことは追って実験結果を参照しつつ説明するが、単に渋みが一方的に感じられにくくなって官能的に逆転したのではなく、渋みが感じられにくくなるのは勿論のこと、甘みが強く感じられるようになって相互に官能的に逆転することが分かっている。 This will be explained later with reference to the experimental results, but it is not just that the astringency is unilaterally less likely to be felt and sensually reversed, but of course the astringency is less likely to be felt and the sweetness is strongly felt. It is known that they are sensually reversed from each other.

すなわち本願は、ハマボウ抽出物の渋みと甘みを相互に官能的に逆転させた乳酸菌体を含有するハマボウ抽出物製剤についても提案する。 That is, the present application also proposes a hamabo extract preparation containing lactic acid bacteria cells in which the astringency and sweetness of the hamabo extract are sensually reversed.

ここで添加される乳酸菌は、経口的に摂取しても衛生的に問題のない乳酸菌出あれば良く、これまでの食品に含まれている乳酸菌であることがより望ましい。このような乳酸菌としては、例えば、Lactobacillus属、Lactococcus属、Enterococcus属、Bifidobacterium属に属する乳酸菌が挙げられる。 The lactic acid bacterium added here may be a lactic acid bacterium that does not cause a hygienic problem even when ingested orally, and it is more desirable that the lactic acid bacterium is contained in conventional foods. Examples of such lactic acid bacteria include lactic acid bacteria belonging to the genus Lactobacillus, the genus Lactococcus, the genus Enterococcus, and the genus Bifidobacterium.

Lactobacillus属に属する乳酸菌としては、例えば、Lactobacillus acidophilus、Lactobacillus brevis、Lactobacillus casei、Lactobacillus delbrueckii subsp. bulgaricus、Lactobacillus delbrueckii subsp. delbrueckii、Lactobacillus delbrueckii subsp. lactis、Lactobacillus gasseri、Lactobacillus helveticus、Lactobacillus kimchii、Lactobacillus paracasei、Lactobacillus plantarum、Lactobacillus rhamnosus、Lactobacillus sakei、Lactobacillus salivariusなどが挙げられるが、勿論これらに限定されるものではない。 Lactobacillus属に属する乳酸菌としては、例えば、Lactobacillus acidophilus、Lactobacillus brevis、Lactobacillus casei、Lactobacillus delbrueckii subsp. bulgaricus、Lactobacillus delbrueckii subsp. delbrueckii、Lactobacillus delbrueckii subsp. lactis、Lactobacillus gasseri、Lactobacillus helveticus、Lactobacillus kimchii、Lactobacillus paracasei、Lactobacillus Examples include, but are not limited to, plantarum, Lactobacillus rhamnosus, Lactobacillus sakei, Lactobacillus salivarius.

また、Lactococcus属に属する乳酸菌としては、例えば、Lactococcus lactis(Lactococcus lactis subsp. cremorisやLactococcus lactis subsp. lactisなど)が挙げられるが、勿論これらに限定されるものではない。 Examples of lactic acid bacteria belonging to the genus Lactococcus include, but are not limited to, Lactococcus lactis (Lactococcus lactis subsp. Cremoris, Lactococcus lactis subsp. Lactis, etc.).

また、Enterococcus属に属する乳酸菌としては、例えば、Enterococcus faecalisやEnterococcus faeciumが挙げられるが、勿論これらに限定されるものではない。 Examples of lactic acid bacteria belonging to the genus Enterococcus include, but are not limited to, Enterococcus faecalis and Enterococcus faecium.

また、Bifidobacterium属に属する乳酸菌としては、例えば、Bifidobacterium animalis subsp. lactis、Bifidobacterium bifidum、Bifidobacterium breve、Bifidobacterium longum subsp. longum、Bifidobacterium longum subsp. infantisなどが挙げられるが、勿論これらに限定されるものではない。 Examples of lactic acid bacteria belonging to the genus Bifidobacterium include, but are not limited to, Bifidobacterium animalis subsp. Lactis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium longum subsp. Longum, and Bifidobacterium longum subsp. Infantis. ..

これらの乳酸菌は、生菌であっても良いが死菌であっても良く、また、単一の菌種や菌株でも良いし、混合培養されたもの(例えば,共生関係にあったり競合しない関係にある複数の乳酸菌を共に培養したもの。)であっても良い。また、乳酸菌による呈味改善効果を消失させない範囲で、経口摂取可能な別の菌を添加することを妨げない。 These lactic acid bacteria may be live bacteria or dead bacteria, may be a single strain or strain, or may be mixed-cultured (for example, a symbiotic relationship or a non-competitive relationship). It may be a culture of a plurality of lactic acid bacteria in the above.). In addition, it does not prevent the addition of another orally ingestible bacterium as long as the taste improving effect of the lactic acid bacterium is not lost.

またこれらの乳酸菌は、ハマボウ抽出物の乾燥物0.1gに対して1.0×105個以上、より好ましくは1.0×106個以上含まれるのが望ましい。このような乳酸菌の原料は、例えば乳発酵により培養されたもの、すなわちヨーグルト等を原料としても良いが、その他培地を用いて培養し収集したものであっても良い。 Further, it is desirable that these lactic acid bacteria are contained in an amount of 1.0 × 10 5 or more, more preferably 1.0 × 10 6 or more, based on 0.1 g of the dried product of Hibiscus hamabo extract. The raw material of such a lactic acid bacterium may be, for example, one cultivated by milk fermentation, that is, yogurt or the like as a raw material, or may be cultivated and collected using another medium.

そして、本実施形態に係るハマボウ抽出物に乳酸菌体を添加してハマボウ抽出物の渋みと甘みの強弱を相互に官能的に逆転させたものは、食品や機能性食品として利用することができる。 Then, a product obtained by adding lactic acid bacteria to the Hibiscus hamabo extract according to the present embodiment and sensually reversing the astringency and sweetness of the Hibiscus hamabo extract can be used as a food or a functional food.

また付言すれば、本願は、ハマボウ抽出物の渋みと甘みの強弱を相互に官能的に逆転させるための乳酸菌体の添加によるハマボウ抽出物用呈味改善剤としての使用方法を提供するものでもあると言える。 In addition, the present application also provides a method of using the Hibiscus hamabo extract as a taste improving agent by adding lactic acid bacteria cells to sensually reverse the astringency and sweetness of the Hibiscus hamabo extract. It can be said that.

そして、ハマボウ抽出物が持つ渋みは、勿論、食品として摂取が憚られる程の渋みではないのであるが、ハマボウ抽出物に対するこのような乳酸菌添加技術によれば、子供から年配層まで幅広く、かつ継続的にハマボウ抽出物含有の食品等を摂取させるのに有用である。 And, of course, the astringency of the Hibiscus hamabo extract is not so astringent that it can be ingested as a food, but according to this technology for adding lactic acid bacteria to the Hibiscus hamabo extract, it continues widely and continuously from children to the elderly. It is useful for ingesting foods containing Hamabou extract.

以下、本実施形態に係るハマボウ抽出物に関し、その製造方法や血糖値、脂肪吸収、血圧、メラニン生成、コラーゲン産生の各観点における影響についての試験を参照しつつ説明する。 Hereinafter, the Hibiscus hamabo extract according to the present embodiment will be described with reference to a test on its production method and its influence on each viewpoint of blood glucose level, fat absorption, blood pressure, melanin production, and collagen production.

〔1.被験サンプルの調製〕
海岸に自生するハマボウより採取したハマボウの葉、枝、種子、種子外殻、花を対象とし、水抽出又はエタノール(EtOH)抽出を行い、更に乾燥を施すことでそれぞれの部位の水抽出物又はエタノール抽出物を得た。
[1. Preparation of test sample]
Water extraction or ethanol (EtOH) extraction is performed on the leaves, branches, seeds, seed shells, and flowers of Hamabou collected from Hamabou that grows naturally on the coast, and further drying is performed to obtain a water extract or a water extract of each part. An ethanol extract was obtained.

ハマボウの各部位は凍結乾燥後に粉砕し、水又はエタノールを抽出溶媒として24時間に亘り振盪抽出(200rpm)を行った。24時間経過後、水を抽出溶媒としたものは遠心分離に供し、その上清を凍結乾燥させて得られた粉末を水抽出物とした。エタノールを抽出溶媒としたものは、ロータリーエバポレータにて濃縮後、デシケータ内で乾固させることでエタノール抽出物とした。各部位の含水率、水抽出率、エタノール抽出率は下記表1の通りである。

Figure 2022077034000002
Each part of Hibiscus hamabo was freeze-dried, crushed, and subjected to shaking extraction (200 rpm) for 24 hours using water or ethanol as an extraction solvent. After 24 hours, those using water as an extraction solvent were subjected to centrifugation, and the supernatant was freeze-dried to obtain a powder obtained as a water extract. Ethanol as an extraction solvent was concentrated in a rotary evaporator and then dried in a desiccator to obtain an ethanol extract. The water content, water extraction rate, and ethanol extraction rate of each part are shown in Table 1 below.
Figure 2022077034000002

〔2.α-グルコシダーゼ活性阻害試験〕
糖尿病は糖代謝の異常により高血糖状態が継続する疾病であり、様々な病気を引き起こす原因ともなる。高血糖状態には生活習慣が大きく影響しており、日常的な血糖値のコントロールが重量である。α-グルコシダーゼは小腸上皮細胞において糖のα-グルコシド結合を加水分解する酵素の複合体であり、二糖類の消化と吸収に関与する。ここでは、血糖値抑制効果を評価すべく、各サンプルのα-グルコシダーゼ活性の測定を行った。
[2. α-Glucosidase activity inhibition test]
Diabetes is a disease in which hyperglycemia continues due to abnormal glucose metabolism, and it also causes various diseases. Lifestyle-related habits have a great influence on hyperglycemic conditions, and daily control of blood glucose levels is weight. α-Glucosidase is a complex of enzymes that hydrolyzes α-glucosidic bonds of sugars in small intestinal epithelial cells and is involved in the digestion and absorption of disaccharides. Here, in order to evaluate the blood glucose level suppressing effect, the α-glucosidase activity of each sample was measured.

評価したサンプルは、葉の水抽出物及びエタノール抽出物、枝の水抽出物及びエタノール抽出物、種子の水抽出物及びエタノール抽出物、種子外殻の水抽出物及びエタノール抽出物の8種である。 The evaluated samples were 8 kinds of water extract and ethanol extract of leaves, water extract and ethanol extract of branches, water extract and ethanol extract of seeds, water extract and ethanol extract of seed shell. be.

α-グルコシダーゼ活性の測定は次の通り行った。0.1Mスクロース溶液と、5U/mlのα-グルコシダーゼ溶液と、サンプル溶液とをそれぞれ100μlずつ分取して混合し、37℃にて30分間反応させた。次いで、100℃に設定したブロックインキュベータにて10分間加熱して反応を停止させた。その後、3分間静置して室温に戻し、撹拌の後に遠心分離機に供してフラッシュし液滴を集合させ、バイオセンサにてグルコースの濃度測定を行った。 The α-glucosidase activity was measured as follows. A 0.1 M sucrose solution, a 5 U / ml α-glucosidase solution, and a sample solution were separated by 100 μl each, mixed, and reacted at 37 ° C. for 30 minutes. Then, the reaction was stopped by heating for 10 minutes in a block incubator set at 100 ° C. Then, it was allowed to stand for 3 minutes, returned to room temperature, stirred, and then flushed with a centrifuge to collect droplets, and the glucose concentration was measured with a biosensor.

サンプル溶液は、上記8種のいずれについても、0.002mg/ml、0.02mg/ml、0.2mg/ml、0.4mg/mlの濃度の液を調製し、それぞれについてα-グルコシダーゼの阻害活性(%)を求めた。水抽出物の阻害活性を図1(a)に示し、エタノール抽出物の阻害活性を図1(b)に示す。なお、ポジティブコントロールとして、DNJ(1-デオキシノジリマイシン)を供した。DNJは桑特有の成分であり、α-グルコシダーゼを強力に阻害し、糖吸収を抑制することが知られている。 For all of the above eight types of sample solutions, prepare solutions with concentrations of 0.002 mg / ml, 0.02 mg / ml, 0.2 mg / ml, and 0.4 mg / ml, and the inhibitory activity (%) of α-glucosidase for each. Asked. The inhibitory activity of the water extract is shown in FIG. 1 (a), and the inhibitory activity of the ethanol extract is shown in FIG. 1 (b). DNJ (1-deoxynojirimycin) was provided as a positive control. DNJ is a component peculiar to morus alba and is known to strongly inhibit α-glucosidase and suppress sugar absorption.

図1(a)に示すように、ハマボウ水抽出物のα-グルコシダーゼ活性を測定した結果、ハマボウ(葉、枝、種子、種子外殻)の水抽出物0.2mg/ml及び0.4mg/mlにおいて強いα-グルコシダーゼ阻害活性を示した。更に、ハマボウ(葉、枝、種子外殻)の水抽出物0.02mg/mlでも、α-グルコシダーゼ阻害活性が64.2、67.9又は76.5%であることが確認できた。 As shown in FIG. 1 (a), as a result of measuring the α-glucosidase activity of the Hamabou water extract, in the Hamabou (leaves, branches, seeds, seed shells) water extract 0.2 mg / ml and 0.4 mg / ml. It showed a strong α-glucosidase inhibitory activity. Furthermore, it was confirmed that the α-glucosidase inhibitory activity was 64.2, 67.9 or 76.5% even with 0.02 mg / ml of a water extract of Hibiscus hamabo (leaves, branches, seed shells).

また、図1(b)に示すように、ハマボウエタノール抽出物のα-グルコシダーゼ活性を測定した結果、ハマボウ(葉、枝、種子、種子外殻)のエタノール抽出物では、0.2mg/ml及び0.4mg/mlで強いα-グルコシダーゼ阻害活性が確認できた。 In addition, as shown in FIG. 1 (b), as a result of measuring the α-glucosidase activity of the Hamabou ethanol extract, the ethanol extract of Hamabou (leaves, branches, seeds, seed shells) was 0.2 mg / ml and 0.4. A strong α-glucosidase inhibitory activity was confirmed at mg / ml.

以上の結果から、ハマボウ(葉、枝、種子、種子外殻)の水抽出物及びエタノール抽出物にはα-グルコシダーゼ阻害活性が認められ、抗糖尿病に関する素材として期待できることが示された。 From the above results, it was shown that the water extract and ethanol extract of Hamabou (leaves, branches, seeds, seed shells) had α-glucosidase inhibitory activity and could be expected as a material for antidiabetes.

〔3.リパーゼ活性阻害試験〕
リパーゼは脂肪を分解する酵素で、膵臓から十二指腸へ分泌される。リパーゼは、脂肪の消化・吸収に大きく関与している。
[3. Lipase activity inhibition test]
Lipase is an enzyme that breaks down fat and is secreted from the pancreas into the duodenum. Lipase is greatly involved in the digestion and absorption of fat.

現在、肥満が原因となり、糖尿病に代表される代謝性疾患や血管疾患などの疾患を抱える人口が急増しており、肥満の解決は急務とされる。肥満は、環境や遺伝など数多くの要因が挙げられるが、肥満の原因自体は消費エネルギーよりも摂取エネルギーが過剰であることに尽きる。膵リパーゼは脂肪の吸収に関与しているため、リパーゼ活性が阻害されるような物質は、摂取エネルギーを低下させ、抗肥満効果を発揮する有効なアプローチの一つとして考えられている。 Currently, the number of people suffering from diseases such as metabolic diseases such as diabetes and vascular diseases is rapidly increasing due to obesity, and it is urgent to solve obesity. Obesity has many factors such as environment and heredity, but the cause of obesity is that it consumes more energy than it consumes. Since pancreatic lipase is involved in fat absorption, substances that inhibit lipase activity are considered as one of the effective approaches to reduce energy intake and exert an anti-obesity effect.

本試験では、各サンプルのリパーゼに対する酵素阻害活性を評価することにより、各サンプルの抗リパーゼ効果について検討する。 In this test, the anti-lipase effect of each sample will be examined by evaluating the enzyme inhibitory activity of each sample against lipase.

試験方法としては、25μlの被験液を50μlの0.1mM 4-Methylumbelliferyl oleate(4-MUO)(/13mM Tris-HCl, 150mM NaCl, 1.3mM CaCl2緩衝液)溶液と混合し、150μg/mlの濃度に調製した25μlのブタ膵臓由来リパーゼ(東京化成工業株式会社製 Lipase from Porcine Pancreas L0057)を更に添加して、25℃にて30分間に亘り反応を行った。 The test method is to mix 25 μl of the test solution with 50 μl of 0.1 mM 4-Methylumbelliferyl oleate (4-MUO) (/ 13 mM Tris-HCl, 150 mM NaCl, 1.3 mM CaCl 2 buffer) solution to a concentration of 150 μg / ml. 25 μl of porcine pancreas-derived lipase (Lipase from Porcine Pancreas L0057 manufactured by Tokyo Kasei Kogyo Co., Ltd.) was further added, and the reaction was carried out at 25 ° C. for 30 minutes.

反応後、100μlの0.1M クエン酸緩衝液(pH4.2)を加えて反応を停止させ、励起波長360nmにて4-MUOにリパーゼが作用して遊離した4-メチルウンベリフェロンの蛍光(465nm)の強度を測定し、被験液がリパーゼ活性に与える影響を評価した。 After the reaction, 100 μl of 0.1 M citrate buffer (pH 4.2) was added to stop the reaction, and lipase acted on 4-MUO at an excitation wavelength of 360 nm to release 4-methylumbelliferone fluorescence (465 nm). ) Was measured, and the effect of the test solution on lipase activity was evaluated.

被験液は、ハマボウの葉の水抽出物及びエタノール抽出物、枝の水抽出物及びエタノール抽出物、種子の水抽出物及びエタノール抽出物、種子外殻の水抽出物及びエタノール抽出物の8種であり、0.5mg/ml、5mg/ml、10mg/mlの濃度の液をそれぞれ調製し、リパーゼ生成阻害率(%)を求めた。また、ポジティブコントロールとして、Orl(オルリスタット、終濃度0.005mg/ml)を使用した。Orlは肥満治療薬の一種であり、腸内のリパーゼに作用し、結果的に腸管からの脂肪の吸収を阻害することが知られている。 There are eight test solutions: water extract and ethanol extract of Hamabou leaves, water extract and ethanol extract of branches, water extract and ethanol extract of seeds, water extract and ethanol extract of seed shells. Therefore, solutions having concentrations of 0.5 mg / ml, 5 mg / ml, and 10 mg / ml were prepared, and the lipase production inhibition rate (%) was determined. Orlistat (final concentration 0.005 mg / ml) was used as a positive control. Orl is a kind of obesity drug and is known to act on lipase in the intestine and eventually inhibit the absorption of fat from the intestinal tract.

図2(a)は、水抽出物のリパーゼ生成阻害率(%)を示したグラフである。図2(a)からも分かるように、葉、枝、種子、種子外殻のいずれにおいても、高濃度である10mg/mlの濃度のサンプルは、オルリスタットと同程度又はそれ以上の強いリパーゼ生成阻害率が確認された。特に、枝の水抽出物は、実施した0.5mg/ml、5mg/ml、10mg/mlのいずれの濃度においても、オルリスタット以上のリパーゼ阻害率が確認された。また、種子の水抽出物については、試験したいずれの濃度においても、オルリスタットと同程度のリパーゼ阻害率が確認された。 FIG. 2A is a graph showing the lipase production inhibition rate (%) of the water extract. As can be seen from FIG. 2 (a), in any of the leaves, branches, seeds, and seed shells, the high concentration sample at a concentration of 10 mg / ml has a strong inhibition of lipase production equal to or higher than that of orlistat. The rate was confirmed. In particular, the water extract of the branch was confirmed to have a lipase inhibition rate higher than that of orlistat at any of the concentrations of 0.5 mg / ml, 5 mg / ml, and 10 mg / ml. In addition, with respect to the water extract of seeds, a lipase inhibition rate similar to that of orlistat was confirmed at any of the tested concentrations.

図2(b)はエタノール抽出物のリパーゼ生成阻害率(%)を示したグラフである。水抽出物と同様に、種子のエタノール抽出物を除いては、高濃度である5mg/ml、10mg/mlにおいてオルリスタットと同程度のリパーゼ生成阻害率(%)が確認された。 FIG. 2B is a graph showing the lipase production inhibition rate (%) of the ethanol extract. Similar to the water extract, except for the ethanol extract of seeds, lipase production inhibition rate (%) similar to that of orlistat was confirmed at high concentrations of 5 mg / ml and 10 mg / ml.

これらの結果から、葉、枝、種子、種子外殻の水抽出物及びエタノール抽出物には、いずれも抗リパーゼ活性の効果を有することが示された。 From these results, it was shown that the water extract and the ethanol extract of the leaves, branches, seeds, seed shells, all had the effect of anti-lipase activity.

〔4.アンジオテンシン変換酵素活性阻害試験〕
アンジオテンシン変換酵素(ACE)は、血圧調節メカニズムの一つであるレニン-アンジオテンシン系において、アンジオテンシンIから、昇圧作用を有するアンジオテンシンIIを生成する。また同時に降圧ペプチドであるブラジキニンを分解するなど、血圧上昇に大きく関与する酵素である。
[4. Angiotensin converting enzyme activity inhibition test]
Angiotensin converting enzyme (ACE) produces angiotensin II, which has a pressor effect, from angiotensin I in the renin-angiotensin system, which is one of the blood pressure regulation mechanisms. At the same time, it is an enzyme that greatly contributes to the increase in blood pressure, such as degrading bradykinin, which is a hypotensive peptide.

本試験では、各サンプルのACEに対する酵素阻害活性を評価することにより、各サンプルの降圧効果について検討する。 In this study, the antihypertensive effect of each sample will be examined by evaluating the enzyme inhibitory activity of each sample against ACE.

ACE活性試験は、ACE Kit-WST(同仁化学研究所)を用いて行った。同キットは、3-Hydroxybutyryl-Gly-Gly-Gly(3HBGGG)より遊離した3-Hydroxybutyric acid(3HB)を酵素法にて検出する方法である。 The ACE activity test was performed using ACE Kit-WST (Dojin Kagaku Kenkyusho). This kit is a method for detecting 3-Hydroxybutyric acid (3HB) released from 3-Hydroxybutyryl-Gly-Gly-Gly (3HBGGG) by an enzymatic method.

水抽出物は超純水に溶解させて被験液を調製し、また、エタノール抽出物はDMSO(Dimethyl sulfoxide)に溶解させて被験液を調製することで、ACE活性試験に供した。サンプルの被験液は、125μg/ml、625μg/ml、3125μg/mlの濃度の液をそれぞれ調製した。またポジティブコントロールとして、超純水又はDMSOに溶解したVal-Tyr(サーディンペプチド)を使用した。 The water extract was dissolved in ultrapure water to prepare a test solution, and the ethanol extract was dissolved in DMSO (Dimethyl sulfoxide) to prepare a test solution, which was subjected to an ACE activity test. The sample test solutions were prepared at concentrations of 125 μg / ml, 625 μg / ml, and 3125 μg / ml, respectively. As a positive control, Val-Tyr (sardine peptide) dissolved in ultrapure water or DMSO was used.

測定には96穴プレートを用いた。各サンプルの測定用ウェルには、20μlの被験液と、20μlのSubstrate bufferと、20μlのEnzyme working solutionを加えた。また、ACE阻害なしのブランク(blank 1)のウェルには、20μlの超純水又はDMSOと、20μlのSubstrate bufferと、20μlのEnzyme working solutionを加えた。また、試薬ブランク(blank 2)のウェルには、40μlの超純水又はDMSOと、20μlのSubstrate bufferを加えた。 A 96-well plate was used for the measurement. 20 μl of test solution, 20 μl of Substrate buffer, and 20 μl of Enzyme working solution were added to the measurement wells of each sample. In addition, 20 μl of ultrapure water or DMSO, 20 μl of Substrate buffer, and 20 μl of Enzyme working solution were added to the wells of the blank (blank 1) without ACE inhibition. In addition, 40 μl of ultrapure water or DMSO and 20 μl of Substrate buffer were added to the wells of the reagent blank (blank 2).

その後、37℃で60分間に亘りインキュベートし、その後、200μlのIndicator working solutionを加えて室温にて10分間インキュベートした。 It was then incubated at 37 ° C. for 60 minutes, then 200 μl of Indicator working solution was added and incubated at room temperature for 10 minutes.

その後、マイクロプレートリーダにて450nmの吸光度を測定し、その値からACE阻害活性率(%)を求め、更に50%阻害濃度(IC50)を算出した。ACE阻害活性率(%)は、下記式( I )に従って求めた。
ACE阻害活性率(%)=[(Ablank1-Asample)/(Ablank1-Ablank2)]×100 ( I )
Then, the absorbance at 450 nm was measured with a microplate reader, the ACE inhibitory activity rate (%) was obtained from the value, and the 50% inhibitory concentration (IC 50 ) was further calculated. The ACE inhibitory activity rate (%) was determined according to the following formula (I).
ACE inhibitory activity rate (%) = [(A blank1 -A sample ) / (A blank1 -A blank2 )] × 100 (I)

図3(a)は、水抽出物のACE阻害活性率(%)を示している。図3(a)に示すように、試験した最も濃い濃度(3125μg/ml)におけるACE阻害活性率は、Val-Tyr(ポジティブコントロール)で99.9%、葉の水抽出物で73.0%、枝の水抽出物で66.8%、種子の水抽出物で86.6%、種子外殻の水抽出物では54.8%であった。 FIG. 3A shows the ACE inhibitory activity rate (%) of the water extract. As shown in FIG. 3 (a), the ACE inhibitory activity rate at the highest concentration (3125 μg / ml) tested was 99.9% for Val-Tyr (positive control), 73.0% for leaf water extract, and branch water. The extract was 66.8%, the water extract of seeds was 86.6%, and the water extract of seed shells was 54.8%.

Val-Tyr(ポジティブコントロール)では、450nmの吸光度値から算出したACEに対するIC50は0.73μg/mlであった。一方、葉の水抽出物で891.3μg/ml、枝の水抽出物で952.1μg/ml、種子の水抽出物で194.9μg/ml、種子外殻の水抽出物では2022.5μg/mlであった。ACEに対する酵素阻害活性は、水抽出物では種子で最も高く、種子外殻で最も低いことが示唆された。 In Val-Tyr (positive control), the IC 50 for ACE calculated from the absorbance value at 450 nm was 0.73 μg / ml. On the other hand, the water extract of leaves was 891.3 μg / ml, the water extract of branches was 952.1 μg / ml, the water extract of seeds was 194.9 μg / ml, and the water extract of seed shells was 2022.5 μg / ml. .. It was suggested that the enzyme inhibitory activity on ACE was highest in seeds and lowest in seed shells in water extract.

図3(b)は、エタノール抽出物のACE阻害活性率(%)を示している。図3(b)に示すように、試験した最も濃い濃度(3125μg/ml)におけるACE阻害活性率は、Val-Tyr(ポジティブコントロール)で90.0%、葉のエタノール抽出物で26.3%、枝のエタノール抽出物で26.3%、種子のエタノール抽出物で15.0%、種子外殻のエタノール抽出物では0%であった。従って、エタノール抽出物のACEに対する阻害活性は、水抽出物と比較して弱いことが示唆された。 FIG. 3 (b) shows the ACE inhibitory activity rate (%) of the ethanol extract. As shown in FIG. 3 (b), the ACE inhibitory activity rate at the highest concentration (3125 μg / ml) tested was 90.0% for Val-Tyr (positive control), 26.3% for leaf ethanol extract, and branch ethanol. The extract was 26.3%, the seed ethanol extract was 15.0%, and the seed shell ethanol extract was 0%. Therefore, it was suggested that the inhibitory activity of the ethanol extract on ACE was weaker than that of the water extract.

これらの結果より、ハマボウの水抽出物には、降圧効果が期待できるACE阻害活性を示す成分が含まれることが示唆された。 From these results, it was suggested that the water extract of Hibiscus hamabo contains a component showing ACE inhibitory activity that can be expected to have an antihypertensive effect.

〔5.メラニン産生評価試験〕
メラニンはフェノール類物質が高分子化して色素になった物質の総称である。メラニンが蓄積し、地肌の色よりも濃く見える部位がシミである。肌が紫外線などの刺激を受けると、皮膚内部のメラニン合成を行うメラニン色素細胞(メラノサイト)が活性化し、メラニンを過剰に生産し、シミの原因となる。
[5. Melanin production evaluation test]
Melanin is a general term for substances in which phenolic substances are polymerized into pigments. Spots are areas where melanin accumulates and looks darker than the background color. When the skin is stimulated by ultraviolet rays or the like, melanin pigment cells (melanocytes) that synthesize melanin inside the skin are activated, producing excessive melanin and causing spots.

一方で、ヒトの髪の毛の色はメラニンの種類や量により決定される。例えば、黒髪にはメラニンが多く含まれており、白髪には殆どメラニンが含まれていない。チロシンを原料としてメラニンが産生され、近接する毛母細胞にメラニン色素が供給される。メラノサイトからのメラニンの供給が行われないと、白髪になってしまうため、メラノサイトが正常に機能することが健康な髪の維持のために重要である。 On the other hand, the color of human hair is determined by the type and amount of melanin. For example, black hair contains a large amount of melanin, and white hair contains almost no melanin. Melanin is produced from tyrosine as a raw material, and melanin pigment is supplied to nearby hair matrix cells. If melanin is not supplied from melanocytes, the hair will become gray, so it is important for melanocytes to function normally in order to maintain healthy hair.

本試験では、マウスメラノーマ細胞株B16を用いて、サンプル添加によるメラニン産生能への影響を評価した。 In this study, mouse melanoma cell line B16 was used to evaluate the effect of sample addition on melanin production.

評価対象サンプルは、ハマボウの花の水抽出物及びエタノール抽出物とした。マウスメラノーマ細胞株(B16)は、DMEM(低グルコース、含1%ペニシリン-ストレプトマイシン及び10%ウシ胎児血清(FBS))を用いて、コンフルエントになるまで75cm2フラスコにて前培養した。その後、24ウェルプレートにてそれぞれ1.0×105cells/mlの濃度で播種しCO2インキュベータ(37℃、5% CO2)にてオーバーナイト培養した。 The samples to be evaluated were water extract and ethanol extract of Hibiscus hamabo flower. Mouse melanoma cell lines (B16) were precultured with DMEM (low glucose, 1% penicillin-streptomycin and 10% fetal bovine serum (FBS)) in 75 cm 2 flasks until confluent. Then, the seeds were sown in a 24-well plate at a concentration of 1.0 × 10 5 cells / ml, and cultured overnight in a CO 2 incubator (37 ° C, 5% CO 2 ).

次に、花の水抽出物又はエタノール抽出物を、オーバーナイト培養後のマウスメラノーマ細胞株に対し、終濃度が10μg/mlとなるように添加し、CO2インキュベータにて72時間培養を行った。またこれと同時に、コントロールとしてDMSO、ポジティブコントロールとしてメラニン合成を阻害する性質を持つアルブチンを終濃度50μg/mlで添加した。 Next, water extract or ethanol extract of flowers was added to the mouse melanoma cell line after overnight culture so that the final concentration was 10 μg / ml, and the cells were cultured in a CO 2 incubator for 72 hours. .. At the same time, DMSO was added as a control, and arbutin, which has the property of inhibiting melanin synthesis as a positive control, was added at a final concentration of 50 μg / ml.

また、本試験では細胞生存率の測定も行った。細胞生存率は、Cell Counting Kit-8(同仁化学)を用いて測定した。細胞外メラニン産生測定用に、細胞上清を除去した24ウェルプレートへDMEM(低グルコース、含1%ペニシリン-ストレプトマイシン)を500μl加えた。次いで、各ウェルに50μlのCCK-8液を添加し、CO2インキュベータにて1時間静置培養した。細胞上清を1.5mlチューブに移し、よく混合した後に100μlずつ96穴ウェルプレートに移し、マイクロプレートリーダで450nmにおける吸光度を測定し、細胞生存率を算出した。 In this test, cell viability was also measured. Cell viability was measured using the Cell Counting Kit-8 (Dojin Kagaku). To measure extracellular melanin production, 500 μl of DMEM (low glucose, 1% penicillin-streptomycin) was added to a 24-well plate from which the cell supernatant had been removed. Then, 50 μl of CCK-8 solution was added to each well, and the cells were statically cultured for 1 hour in a CO 2 incubator. The cell supernatant was transferred to a 1.5 ml tube, mixed well, and then 100 μl each was transferred to a 96-well well plate, and the absorbance at 450 nm was measured with a microplate reader to calculate the cell viability.

細胞内メラニン産生の測定は、細胞上清を除去した24ウェルプレートをPBSにて洗浄後、0.25%トリプシン-EDTA溶液にて細胞を剥離させ、それぞれのウェルから細胞を回収した。遠心、洗浄操作の後、細胞を1.5mlチューブに移して再度遠心後、上清を取り除き、1M NaOH溶液を120μlずつ加えた。100℃で10分間反応させた後に、懸濁液を100μlずつ96穴プレートに移し、プレートリーダーで405nmの吸光度の測定を行った。 For the measurement of intracellular melanin production, a 24-well plate from which the cell supernatant had been removed was washed with PBS, the cells were detached with a 0.25% trypsin-EDTA solution, and the cells were collected from each well. After centrifugation and washing, the cells were transferred to a 1.5 ml tube, centrifuged again, the supernatant was removed, and 120 μl of 1M NaOH solution was added. After reacting at 100 ° C. for 10 minutes, 100 μl of the suspension was transferred to a 96-well plate, and the absorbance at 405 nm was measured with a plate reader.

図4は、ハマボウの花の水抽出物又はエタノール抽出物を添加した後のメラニン産生率を示したグラフである。図4からも分かるように、コントロール(水)と比較して、花の水抽出物を添加することにより、メラニン産生の抑制傾向が認められた。また、花のエタノール抽出物の場合においても、コントロール(DMSO)と比較して、メラニン産生の抑制傾向が見られた。 FIG. 4 is a graph showing the melanin production rate after adding a water extract or an ethanol extract of Hibiscus hamabo flowers. As can be seen from FIG. 4, a tendency to suppress melanin production was observed by adding a water extract of flowers as compared with the control (water). Also, in the case of the ethanol extract of flowers, a tendency to suppress melanin production was observed as compared with the control (DMSO).

以上の結果から、水抽出物及びエタノール抽出物には、メラニン産生を抑制する成分が含まれ、皮膚のシミ予防に効果を発揮しうることが示唆された。 From the above results, it was suggested that the water extract and the ethanol extract contain a component that suppresses melanin production and can be effective in preventing skin spots.

〔6.コラーゲン産生評価試験〕
皮膚真皮の繊維芽細胞は、ヒアルロン酸やコラーゲンといった肌を構成する上で重要な成分を産生する。コラーゲンは、動物の皮膚などの結合組織を形成する構造タンパク質である。コラーゲンは皮膚の強度を保ち、シワのない若々しい肌を保つために重要である。
[6. Collagen production evaluation test]
Skin Fibroblasts in the dermis produce important constituents of the skin, such as hyaluronic acid and collagen. Collagen is a structural protein that forms connective tissues such as animal skin. Collagen is important for maintaining skin strength and keeping youthful, wrinkle-free skin.

繊維芽細胞のコラーゲン産生を促進することができれば、瑞々しく、張りのある皮膚を維持することができると考えられる。本試験では、ヒト繊維芽細胞に被験物質を添加し、コラーゲンの産生能の変化を測定することで、被験物質における肌の水分保持効果、シワ予防に関する評価を行う。 If it is possible to promote collagen production in fibroblasts, it is considered that fresh and firm skin can be maintained. In this test, a test substance is added to human fibroblasts and changes in collagen production ability are measured to evaluate the skin's water retention effect and wrinkle prevention in the test substance.

試験は、成人ヒト皮膚繊維芽細胞(NHDF-Ad)をモデル細胞として用いた。NHDF-Ad細胞は、Dulbecco's Modified Eagle Medium (DMEM)(高グルコース)(含1%ペニシリン-ストレプトマイシン及び10%ウシ胎児血清(FBS))を用いて、コンフルエントになるまでφ10cmディッシュにて前培養した。その後、リン酸緩衝生理食塩水(PBS)で洗浄し、培地に再懸濁後、96穴プレートに0.5×104cells/wellの濃度で播種しCO2インキュベータ(37℃、5% CO2)でオーバーナイト培養した。 The test used adult human skin fibroblasts (NHDF-Ad) as model cells. NHDF-Ad cells were precultured in a φ10 cm dish with Dulbecco's Modified Eagle Medium (DMEM) (high glucose) (including 1% penicillin-streptomycin and 10% fetal bovine serum (FBS)) until confluent. Then, it was washed with phosphate buffered saline (PBS), resuspended in the medium, and then seeded on a 96-well plate at a concentration of 0.5 × 10 4 cells / well in a CO 2 incubator (37 ° C, 5% CO 2 ). Was cultured overnight in.

オーバーナイト培養後、サンプルを含む無血清培地(含む1%ペニシリン-ストレプトマイシン)に交換し、CO2インキュベータにて72時間培養した。サンプルは終濃度10、100、200μg/mlで添加した。 After overnight culture, the cells were replaced with a serum-free medium containing a sample (containing 1% penicillin-streptomycin) and cultured in a CO 2 incubator for 72 hours. Samples were added at final concentrations of 10, 100 and 200 μg / ml.

サンプル添加72時間後の培養上清を回収し、産生されたコラーゲン量を市販のELISAキット(株式会社エーセル製 Human Collagen Type I ELISAキット)にて測定した。 The culture supernatant 72 hours after the sample addition was collected, and the amount of collagen produced was measured with a commercially available ELISA kit (Human Collagen Type I ELISA kit manufactured by Acel Co., Ltd.).

図5(a)は、花の水抽出物を添加して72時間経過後のコラーゲン産生比を示したグラフである。図5(a)に示すように、コントロール(水)と比較して、花の水抽出物を添加したことにより、コラーゲン産生の亢進傾向が認められた。この傾向は特に、濃度を10μg/mlや100μg/mlとしたサンプルにおいて認められた。 FIG. 5A is a graph showing the collagen production ratio 72 hours after the addition of the water extract of flowers. As shown in FIG. 5 (a), a tendency of increased collagen production was observed by adding the water extract of the flower as compared with the control (water). This tendency was particularly observed in samples with concentrations of 10 μg / ml and 100 μg / ml.

図5(b)は、花のエタノール抽出物を添加して72時間経過後のコラーゲン産生比を示したグラフである。図5(b)から分かるように、10μg/mlや100μg/ml、200μg/ml添加によりコントロール(DMSO)と比較してコラーゲン産生の亢進傾向が認められた。 FIG. 5B is a graph showing the collagen production ratio 72 hours after the addition of the flower ethanol extract. As can be seen from FIG. 5 (b), the addition of 10 μg / ml, 100 μg / ml, and 200 μg / ml showed a tendency to increase collagen production as compared with the control (DMSO).

以上の結果から、ハマボウの花の水抽出物やエタノール抽出物には、コラーゲンの産生を亢進し、皮膚の保湿に寄与する成分が含まれていることが示唆された。 From the above results, it was suggested that the water extract and ethanol extract of Hibiscus hamabo contain components that enhance collagen production and contribute to skin moisturization.

〔7.化粧料〕
次に、本実施形態に係るハマボウ抽出物を含有する化粧料について、その製造や肌に対する効果の点について説明する。
[7. Cosmetics]
Next, the cosmetics containing the Hibiscus hamabo extract according to the present embodiment will be described in terms of their production and effects on the skin.

(7-1.化粧料の製造)
ここでは、本実施形態に係る化粧料の一例として、ハマボウ抽出物を含む化粧水を調製した。具体的には、8.0重量部の1,3-ブタンジオールと、6.0重量部のジプロピレングリコールと、20.0重量部のグリセリンと、0.5重量部のソルビトールと、0.3重量部のジラウロイルグルタミン酸リシンNaと、終濃度が10μg/mlとなる量のハマボウの花の抽出物と、水とを混合し、常温で透明に均一溶解するまで攪拌し、100重量部の化粧水を調製した。なお、ハマボウの花の抽出物は、水抽出物を用いたものと、エタノール抽出物を用いたものの2種を調製した。
(7-1. Manufacture of cosmetics)
Here, as an example of the cosmetics according to the present embodiment, a lotion containing a Hibiscus hamabo extract was prepared. Specifically, 8.0 parts by weight of 1,3-butanediol, 6.0 parts by weight of dipropylene glycol, 20.0 parts by weight of glycerin, 0.5 parts by weight of sorbitol, and 0.3 parts by weight of lysine dilauroyl glutamate Na. , The extract of Hamabou flower having a final concentration of 10 μg / ml and water were mixed and stirred at room temperature until they were transparently and uniformly dissolved to prepare 100 parts by weight of lotion. Two kinds of flower extracts of Hibiscus hamabo were prepared, one using a water extract and the other using an ethanol extract.

(7-2.効果確認)
40~60代の男女14名を対象に、1ヶ月に亘り化粧水を使用させることで、メラニン生成抑制効果とコラーゲン産生促進効果について確認を行った。被験者には、朝、昼、就寝前の1日3回のタイミングで約3~5mlの化粧水を腕に塗布させた。一方の腕には抽出物を含んだ化粧水を使用させ、他方の腕には抽出物を含まない化粧水をコントロールとして使用させた。また、被験者は無作為に2群に分け、第1群には水抽出物を含む化粧水を、第2群にはエタノール抽出物を含む化粧水を使用させた。効果の確認は、被験者自身の目視及び触感により、試験開始前の状態と比較することで行った。評価は、「0:変化なし」「1:僅かに改善」「2:やや改善」「3:大きく改善」の4段階で行い、平均点が1以上の場合を効果有りと判断した。その結果を表2に示す。

Figure 2022077034000003
(7-2. Confirmation of effect)
We confirmed the effect of suppressing melanin production and the effect of promoting collagen production by letting 14 men and women in their 40s and 60s use lotion for one month. The subjects were allowed to apply about 3 to 5 ml of lotion to their arms three times a day in the morning, noon, and before going to bed. One arm was made to use a lotion containing an extract, and the other arm was made to use a lotion containing no extract as a control. The subjects were randomly divided into two groups, and the first group used a lotion containing a water extract, and the second group used a lotion containing an ethanol extract. The effect was confirmed by comparing with the state before the start of the test by the subject's own visual and tactile sensation. The evaluation was performed in four stages of "0: no change", "1: slightly improved", "2: slightly improved", and "3: greatly improved", and when the average score was 1 or more, it was judged to be effective. The results are shown in Table 2.
Figure 2022077034000003

表2に示すように、メラニン生成抑制効果に関しては、エタノール抽出物に比して水抽出物の方が若干効果に優れる傾向がみられたものの、いずれもメラニンの産生が効果的に抑制される結果となった。 As shown in Table 2, regarding the effect of suppressing melanin production, the water extract tended to be slightly more effective than the ethanol extract, but the production of melanin was effectively suppressed in both cases. The result was.

また、肌の張りについても、水抽出物とエタノール抽出物はともに良好な結果が得られ、本実施形態に係る化粧水はコラーゲン産生を促進できることが示唆された。 In addition, good results were obtained for both the water extract and the ethanol extract for skin tension, suggesting that the cosmetic water according to the present embodiment can promote collagen production.

〔8.乳酸菌添加による呈味改善試験〕
(8-1.乳酸菌体末の調製)
被験食品に添加するための乳酸菌末の調製をLactobacillus属に属する乳酸菌としてLactobacillus acidophilus、Lactobacillus casei、Lactobacillus delbrueckii subsp. bulgaricus、Lactobacillus delbrueckii subsp. lactis、Lactobacillus plantarumの5種、Lactococcus属に属する乳酸菌としてLactococcus lactis subsp. cremoris、Lactococcus lactis subsp. lactisの2種、Enterococcus属に属する乳酸菌としてEnterococcus faecalis、Enterococcus faeciumの2種、Bifidobacterium属に属する乳酸菌としてBifidobacterium bifidum、Bifidobacterium longum subsp. longumの2種について行った。
[8. Taste improvement test by adding lactic acid bacteria]
(8-1. Preparation of lactic acid bacteria powder)
Preparation of lactic acid bacteria powder for addition to test foods: Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus delbrueckii subsp. Bulgaricus, Lactobacillus delbrueckii subsp. Two types of subsp. cremoris and Lactococcus lactis subsp. Lactis, two types of lactic acid bacteria belonging to the genus Enterococcus, Enterococcus faecalis and Enterococcus faecium, and two types of lactic acid bacteria belonging to the genus Bifidobacterium, Bifidobacterium bifidum and Bifidobacterium longum subsp. Longum.

各菌種に適した液体培地をオートクレーブにて滅菌しつつ脱気し、冷却後に植菌し、各菌種に適した気相条件や振盪・静置条件にて至適温度下で培養を行った。 Degas the liquid medium suitable for each bacterial species while sterilizing it in an autoclave, inoculate after cooling, and culture under the optimum temperature under the vapor phase conditions and shaking / standing conditions suitable for each bacterial species. rice field.

次に、培養した培養液から所定量を採取して適宜段階希釈し、寒天培地に播種し所定時間培養の後にコロニーをカウントすることで生菌数の測定を行った。なお、その間培養液は遠心分離に供して菌体の回収が行われ、滅菌生理食塩水による数回の洗浄及び遠心分離の後に乾燥させ粉末化した。 Next, a predetermined amount was collected from the cultured culture solution, diluted appropriately, seeded on an agar medium, cultured for a predetermined time, and then the colonies were counted to measure the viable cell count. During that period, the culture broth was subjected to centrifugation to recover the cells, washed several times with sterile physiological saline and centrifuged, and then dried and pulverized.

求められた単位液量当たりの生菌数と遠心分離前の培養液の量から培養液全体に含まれていた生菌数を算出し、経験に基づく回収効率を勘案の上、乳酸菌末1gあたりに含まれる菌体の数を算出した。 The number of viable bacteria contained in the entire culture solution was calculated from the calculated number of viable bacteria per unit liquid volume and the amount of culture solution before centrifugation, and after considering the recovery efficiency based on experience, per 1 g of lactic acid bacteria powder. The number of bacterial cells contained in was calculated.

また同様に、対照となる被験食品調製のため、同様にして酵母(Saccharomyces cerevisiae)及び納豆菌(Bacillus subtilis var. natto)についても菌体末の調製を行った。 Similarly, yeast (Saccharomyces cerevisiae) and Bacillus subtilis (Bacillus subtilis var. Natto) were also prepared in the same manner for the preparation of the test food to be used as a control.

(8-2.被験食品の調製)
後述の官能試験を行うにあたり、抽出溶媒、菌体末の有無又は種類、菌体末の添加量の3点をそれぞれ違えた顆粒状の被験食品の調製を行った。被験食品は、呈味への影響が少ない結晶セルロースを賦形剤として使用し、一包2gで統一した。
(8-2. Preparation of test food)
In conducting the sensory test described later, granular test foods were prepared in which the extraction solvent, the presence or absence or type of bacterial cell powder, and the amount of bacterial cell powder added were different from each other. The test food used crystalline cellulose, which has little effect on taste, as an excipient, and was unified in a package of 2 g.

具体的には、ハマボウの葉又は枝の水抽出物又はエタノール抽出物を含むが、いずれの菌体末も添加しない比較対照となる被験食品(以下、無添加被験食品という。)と、ハマボウの葉の水抽出物又はエタノール抽出物を含み、乳酸菌体を含む被験食品(以下、乳酸菌含有被験食品という。)と、ハマボウの葉の水抽出物又はエタノール抽出物を含み、酵母又は納豆菌の菌体を含む被験食品(以下、酵母含有被験食品又は納豆菌含有被験食品という。)を調製した。 Specifically, a test food (hereinafter referred to as additive-free test food) as a comparative control, which contains a water extract or an ethanol extract of leaves or branches of Hamabou but does not contain any bacterial powder, and Hamabo. A test food containing a water extract or an ethanol extract of leaves and containing lactic acid bacteria (hereinafter referred to as a test food containing lactic acid bacteria) and a water extract or ethanol extract of Hamabou leaves, and a fungus of yeast or natto bacteria. A test food containing a body (hereinafter referred to as a yeast-containing test food or a natto bacterium-containing test food) was prepared.

無添加被験食品は、一包2gを摂取した際に、ハマボウ抽出物由来の渋みと甘みの存在が明確に分かる量(約0.1g)の水抽出物末又はエタノール抽出物末を含有させた。 The additive-free test food contained an amount (about 0.1 g) of water extract powder or ethanol extract powder in which the presence of astringency and sweetness derived from Hibiscus hamabo extract was clearly apparent when 2 g of one packet was ingested.

乳酸菌含有被験食品は、無添加被験食品と同様の水抽出物末又はエタノール抽出物末を含有させた上で、前述の11種の乳酸菌末別に調製し、また、それぞれの乳酸菌末について添加量を1.0×104個/一包、1.0×105個/一包、1.0×106個/一包としたものを調製した。 The lactic acid bacterium-containing test food contains the same water extract powder or ethanol extract powder as the additive-free test food, and is prepared for each of the above-mentioned 11 types of lactic acid bacterium powder, and the amount of each lactic acid bacterium powder added is adjusted. 1.0 × 10 4 pieces / packet, 1.0 × 10 5 pieces / package, 1.0 × 10 6 pieces / package were prepared.

酵母含有被験食品又は納豆菌含有被験食品も、乳酸菌含有被験食品と同様に、無添加被験食品と同様の水抽出物末又はエタノール抽出物末を含有させた上で、菌体末別に調製し、また、それぞれの菌体末について添加量を1.0×104個/一包、1.0×105個/一包、1.0×106個/一包としたものを調製した。 Like the test food containing lactic acid bacteria, the test food containing yeast or the test food containing natto bacteria is also prepared according to the bacterial cell powder after containing the same water extract powder or ethanol extract powder as the additive-free test food. In addition, the amount of each bacterial cell powder added was 1.0 × 10 4 / packet, 1.0 × 10 5 / packet, 1.0 × 10 6 / packet.

(8-3.官能試験)
官能評価試験は、健康食品等のOEM製造を行う事業所内にて長年にわたり商品試作や官能評価に携わる5名をパネリストとして選定し、渋みと甘みのバランスについて評価した。
(8-3. Sensory test)
In the sensory evaluation test, five people who have been involved in product trial production and sensory evaluation for many years were selected as panelists in the business establishment that manufactures health foods on an OEM basis, and the balance between astringency and sweetness was evaluated.

被験食品の内容は、無添加食品のみパネリストに対して開示し、その他の被験食品の内容は非開示とした。パネリストは、摂取した被験食品が無添加食品と比較して渋みと甘みのバランスに変化が生じたか否かについて評価を行った。なお、渋みと甘みのバランスの基準について確認が必要なときは、各パネリストは適宜無添加食品を摂取することが許可された。また、5名の各パネリストは、官能試験に先立って行われた予備官能試験にて、渋み成分と甘み成分を種々のバランスにて配合した水溶液を試飲させることで、評価の度合いがおおよそ揃うように訓練が行われている。 The contents of the test foods were disclosed to the panelists only for the additive-free foods, and the contents of the other test foods were not disclosed. The panelists evaluated whether the ingested test food had a change in the balance between astringency and sweetness compared to the additive-free food. When it was necessary to confirm the criteria for the balance between astringency and sweetness, each panelist was allowed to ingest additive-free foods as appropriate. In addition, each of the five panelists was allowed to sample an aqueous solution containing various balances of astringent and sweet ingredients in a preliminary sensory test conducted prior to the sensory test so that the degree of evaluation would be roughly the same. Training is being carried out.

その結果、酵母含有被験食品又は納豆菌含有被験食品は、ハマボウ抽出物由来の渋みと甘みのバランスに対し影響を与えなかった。 As a result, the yeast-containing test food or the natto-containing test food did not affect the balance of astringency and sweetness derived from the Hamabou extract.

一方、乳酸菌含有被験食品は、1.0×104個/一包の被験食品についてはハマボウ抽出物由来の渋みと甘みのバランスに対し影響が見られなかったものの、1.0×106個/一包としたものについては、渋みと甘みのバランスが逆転するという傾向が見られた。また、1.0×105個/一包の被験食品については、1.0×106個/一包の被験食品ほどではないが、渋みと甘みのバランスが逆転するという傾向が見られた。なお、乳酸菌の種類や抽出溶媒による違いは見られなかった。 On the other hand, for the test food containing lactic acid bacteria, 1.0 x 10 4 pieces / pack did not affect the balance of astringency and sweetness derived from the Hamabou extract, but 1.0 x 10 6 pieces / pack. There was a tendency for the balance between astringency and sweetness to reverse. In addition, the balance between astringency and sweetness tended to be reversed for the 1.0 x 10 5 pieces / pack of test food, although not as much as the 1.0 x 10 6 pieces / pack of test food. No difference was observed depending on the type of lactic acid bacteria and the extraction solvent.

また、パネリストに対し意見を聴取したところ、単に渋みが一方的に感じられにくくなって官能的に逆転したのではなく、渋みが感じられにくくなるのは勿論のこと、甘みが強く感じられるようになって相互に官能的に逆転するとの見解が共通意見として得られた。 In addition, when we asked the panelists for their opinions, it was not just that the astringency was unilaterally felt and sensually reversed, but that the astringency was less likely to be felt and that the sweetness was strongly felt. The common opinion was that they would sensually reverse each other.

これらの結果から、Lactobacillus属、Lactococcus属、Enterococcus属、Bifidobacterium属から選ばれる少なくともいずれか1つの属の乳酸菌体が、前記ハマボウ抽出物の乾燥物0.1gあたり1.0×105個以上、より好ましくは1.0×106個以上添加された機能性食品は、ハマボウ抽出物由来の渋みと甘みのバランスが逆転し、呈味改善が成されることが示された。また、葉以外に由来する抽出物についても、似たような味を呈することから、同様の呈味改善が期待されることが示唆された。 From these results, the number of lactic acid bacteria of at least one genus selected from the genus Lactobacillus, Lactococcus, Enterococcus, and Bifidobacterium is 1.0 × 10 5 or more per 0.1 g of the dried product of the Hamabou extract, more preferably. It was shown that the balance of astringency and sweetness derived from Hamabou extract was reversed and the taste was improved in the functional food to which 1.0 × 10 6 or more were added. In addition, extracts derived from other than leaves also exhibit similar tastes, suggesting that similar taste improvement is expected.

上述してきたように、本実施形態に係るハマボウ抽出物によれば、水を主成分とする水系溶媒又はジメチルスルホキシド、エタノール、メタノール、ヘキサンから選ばれるいずれか1つ若しくはいずれか2つ以上の混合液からなる非水系特定溶媒に対して溶解性を示す成分群よりなり、血糖値上昇抑制成分と脂肪吸収抑制成分とメラニン生成抑制成分とコラーゲン産生促進成分とを少なくとも含有するハマボウ抽出物としたため、加齢と共に気になることが多い血糖値や脂質の摂取、また肌の色素沈着や弾力の改善を、ハマボウという単一の植物由来の抽出物にて実現することができる。 As described above, according to the Hamabou extract according to the present embodiment, an aqueous solvent containing water as a main component or a mixture of any one or two or more selected from dimethylsulfoxide, ethanol, methanol and hexane. This is a Hamabou extract that consists of a group of components that are soluble in a specific non-aqueous solvent consisting of a liquid and contains at least a blood glucose level increase inhibitory component, a lipid absorption inhibitory component, a melanin production inhibitory component, and a collagen production promoting component. Ingestion of blood glucose levels and lipids, which are often anxious with aging, and improvement of skin pigmentation and elasticity can be realized with a single plant-derived extract called Hamabou.

最後に、上述した各実施の形態の説明は本発明の一例であり、本発明は上述の実施の形態に限定されることはない。このため、上述した各実施の形態以外であっても、本発明に係る技術的思想を逸脱しない範囲であれば、設計等に応じて種々の変更が可能であることは勿論である。 Finally, the description of each embodiment described above is an example of the present invention, and the present invention is not limited to the above-described embodiment. Therefore, it goes without saying that various changes can be made according to the design and the like as long as the technical idea of the present invention is not deviated from the above-described embodiments.

Claims (8)

水を主成分とする水系溶媒又はジメチルスルホキシド、エタノール、メタノール、ヘキサンから選ばれるいずれか1つ若しくはいずれか2つ以上の混合液からなる非水系特定溶媒に対して溶解性を示す成分群よりなり、血糖値上昇抑制成分と脂肪吸収抑制成分とメラニン生成抑制成分とコラーゲン産生促進成分とを少なくとも含有するハマボウ抽出物。 It consists of a group of components exhibiting solubility in a non-aqueous specific solvent consisting of an aqueous solvent containing water as a main component or a mixed solution of any one or two or more selected from dimethylsulfoxide, ethanol, methanol, and hexane. , Hamabou extract containing at least a component for suppressing increase in blood glucose level, a component for suppressing fat absorption, a component for suppressing melanin production, and a component for promoting collagen production. 前記成分群は水系溶媒に溶解性を示す成分群よりなり、血圧上昇抑制成分を更に含有することを特徴とする請求項1に記載のハマボウ抽出物。 The Hamabou extract according to claim 1, wherein the component group comprises a component group exhibiting solubility in an aqueous solvent and further contains a component for suppressing an increase in blood pressure. 請求項1に記載のハマボウ抽出物を含有する化粧料。 A cosmetic containing the Hibiscus hamabo extract according to claim 1. 請求項1又は請求項2に記載のハマボウ抽出物を含有する機能性食品。 A functional food containing the Hibiscus hamabo extract according to claim 1 or 2. Lactobacillus属、Lactococcus属、Enterococcus属、Bifidobacterium属から選ばれる少なくともいずれか1つの属の乳酸菌体が、前記ハマボウ抽出物の乾燥物0.1gあたり1.0×105個以上添加された請求項4に記載の機能性食品。 The fourth aspect of claim 4, wherein 1.0 × 10 5 or more lactic acid bacteria cells of at least one genus selected from the genus Lactobacillus, Lactococcus, Enterococcus, and Bifidobacterium are added per 0.1 g of the dried product of the Hamabou extract. Functional food. 水を主成分とする水系溶媒又はジメチルスルホキシド、エタノール、メタノール、ヘキサンから選ばれるいずれか1つ若しくはいずれか2つ以上の混合液からなる非水系特定溶媒に対して溶解性を示す成分群よりなるハマボウ抽出物の、前記ハマボウ抽出物に由来する血糖値上昇抑制、脂肪吸収抑制、メラニン生成抑制、コラーゲン産生促進、血圧上昇抑制から選ばれる少なくともいずれか1つの事象を作用又は効果として含む目的のための機能性食品における、前記事象の発現と対応する前記ハマボウ抽出物の構成成分を保健機能成分(関与成分)とした機能性食品の原料としての使用。 It consists of a group of components exhibiting solubility in a non-aqueous specific solvent consisting of an aqueous solvent containing water as a main component or a mixed solution of any one or two or more selected from dimethylsulfoxide, ethanol, methanol and hexane. For the purpose of including at least one event selected from the Hamabou extract, that is, the suppression of blood glucose level increase, the suppression of fat absorption, the suppression of melanin production, the promotion of collagen production, and the suppression of blood pressure increase derived from the Hamabou extract as an action or effect. Use as a raw material for functional foods in which the constituents of the Hamabou extract corresponding to the occurrence of the above-mentioned events are used as health functional ingredients (participating ingredients) in the functional foods of the above. 水を主成分とする水系溶媒又はジメチルスルホキシド、エタノール、メタノール、ヘキサンから選ばれるいずれか1つ若しくはいずれか2つ以上の混合液からなる非水系特定溶媒に対して溶解性を示す成分群よりなるハマボウ抽出物の、前記ハマボウ抽出物に由来するメラニン生成抑制又はコラーゲン産生促進の少なくともいずれか1つの事象を作用又は効果として含む目的のための化粧料における、前記事象の発現と対応する前記ハマボウ抽出物の構成成分を有効成分とした化粧料の原料としての使用。 It consists of a group of components exhibiting solubility in a non-aqueous specific solvent consisting of an aqueous solvent containing water as a main component or a mixed solution of any one or two or more selected from dimethylsulfoxide, ethanol, methanol and hexane. The Hamabou corresponding to the manifestation of the event in a cosmetic for the purpose of comprising at least one event of suppressing melanin production or promoting collagen production derived from the Hamabou extract as an action or effect. Use as a raw material for cosmetics containing the constituents of the extract as active ingredients. ハマボウ抽出物の渋みと甘みの強弱を相互に官能的に逆転させるための乳酸菌体のハマボウ抽出物用の呈味改善用添加剤としての使用。 Use as a taste-improving additive for Hamabou extract of lactic acid bacteria cells to sensually reverse the astringency and sweetness of Hamabou extract.
JP2021183685A 2020-11-10 2021-11-10 Use of lactic acid bacteria as an additive for improving the taste of Hamabou extract Active JP7388748B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020187586 2020-11-10
JP2020187586 2020-11-10

Publications (2)

Publication Number Publication Date
JP2022077034A true JP2022077034A (en) 2022-05-20
JP7388748B2 JP7388748B2 (en) 2023-11-29

Family

ID=81618085

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021183685A Active JP7388748B2 (en) 2020-11-10 2021-11-10 Use of lactic acid bacteria as an additive for improving the taste of Hamabou extract

Country Status (1)

Country Link
JP (1) JP7388748B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115403444A (en) * 2022-09-08 2022-11-29 嘉兴学院 Low-temperature recovery method of tetrachloroethylene in fur dry-cleaning waste

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000239164A (en) * 1999-02-19 2000-09-05 Kikkoman Corp Glycosidase inhibitor
JP2006306863A (en) * 2005-03-31 2006-11-09 Kobayashi Pharmaceut Co Ltd Melanin formation inhibitor
JP2010126474A (en) * 2008-11-27 2010-06-10 Ito En Ltd Oral administration composition using extract of plant of genus hibiscus, family malvaceae
CN102659802A (en) * 2012-04-27 2012-09-12 江苏省中国科学院植物研究所 Preparation method of coumarin lignan compounds and application of coumarin lignan compounds in resisting marine fouling
JP2013078265A (en) * 2011-09-30 2013-05-02 Riken Vitamin Co Ltd Taste improving agent for acidic food and drink
KR20140145257A (en) * 2013-06-12 2014-12-23 중앙대학교 산학협력단 Composition for whitening comprising extract of Rhododendron molle (Blume) G. Don
KR101475609B1 (en) * 2013-06-12 2014-12-23 중앙대학교 산학협력단 Composition for whitening comprising extract of Miscanthus sinensis var. purpurascens
KR101883307B1 (en) * 2017-05-22 2018-07-31 주식회사 코리아나화장품 Cosmetic composition for improving skin wrinkle comprising extracts of hibiscus hamabo leaf as active ingredient

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000239164A (en) * 1999-02-19 2000-09-05 Kikkoman Corp Glycosidase inhibitor
JP2006306863A (en) * 2005-03-31 2006-11-09 Kobayashi Pharmaceut Co Ltd Melanin formation inhibitor
JP2010126474A (en) * 2008-11-27 2010-06-10 Ito En Ltd Oral administration composition using extract of plant of genus hibiscus, family malvaceae
JP2013078265A (en) * 2011-09-30 2013-05-02 Riken Vitamin Co Ltd Taste improving agent for acidic food and drink
CN102659802A (en) * 2012-04-27 2012-09-12 江苏省中国科学院植物研究所 Preparation method of coumarin lignan compounds and application of coumarin lignan compounds in resisting marine fouling
KR20140145257A (en) * 2013-06-12 2014-12-23 중앙대학교 산학협력단 Composition for whitening comprising extract of Rhododendron molle (Blume) G. Don
KR101475609B1 (en) * 2013-06-12 2014-12-23 중앙대학교 산학협력단 Composition for whitening comprising extract of Miscanthus sinensis var. purpurascens
KR101883307B1 (en) * 2017-05-22 2018-07-31 주식회사 코리아나화장품 Cosmetic composition for improving skin wrinkle comprising extracts of hibiscus hamabo leaf as active ingredient

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115403444A (en) * 2022-09-08 2022-11-29 嘉兴学院 Low-temperature recovery method of tetrachloroethylene in fur dry-cleaning waste
CN115403444B (en) * 2022-09-08 2023-12-22 嘉兴学院 Low-temperature recovery method of tetrachloroethylene in fur dry-cleaning waste

Also Published As

Publication number Publication date
JP7388748B2 (en) 2023-11-29

Similar Documents

Publication Publication Date Title
JP6737779B2 (en) Method for producing microbial preparation and microbial preparation produced thereby
JP4795841B2 (en) Germinated barley fermented product
EP2474237B1 (en) Equol-containing fermentation product of soybean embryonic axis, and method for production thereof
WO2007073122A1 (en) Composition for protecting and improving skin comprising the rice bran fermented by lactic acid bacteria
JP4942322B2 (en) Skin fibroblast proliferation promoter
CN108926521A (en) Plant fermentation object
KR101782307B1 (en) Cosmetic composition for Anti-aging comprising Agastache rugosa Kentz extract
JP4492956B2 (en) Fermented acerola
WO2018155660A1 (en) Composition containing dead cell bodies of lactic acid bacterium or treated product thereof, and cosmetic, household good, drug or food containing said composition
TW201225989A (en) Sugar-free pineapple extract, production method thereof, and application thereof
JP7406839B2 (en) Skin external preparations
JP2019034899A (en) External composition for skin
KR100843745B1 (en) Fermented spirulina extract and method for preparing the same
KR100974627B1 (en) Fermented spirulina extract and method for preparing the same
TWI807545B (en) Method of producing encapsulated probiotics, encapsulated probiotics, food or functional health food, pharmaceutical composition or a medicament, and cosmetic composition comprising the same
KR101914345B1 (en) A moisturizing and anti-wrinkle cosmetic composition comprising fermented soybean, fermented rice, fermented potato, fermented ginseng and fermented adlay extract and preparation method of thereof
KR102311097B1 (en) Aerobic fermented product of colostrum
JP7388748B2 (en) Use of lactic acid bacteria as an additive for improving the taste of Hamabou extract
KR100723844B1 (en) Health care and skin care bath and beauty material using fermented soybean extract
KR20160074116A (en) Cosmetic composition containing Crataegis fructus fermented extract
KR20190061544A (en) Cosmetic Composition for Anti-oxidation and Whitening comprising fermented silkworm extract as effective component
JP2018193336A (en) Skin external preparation
JP2003171300A (en) Melanization inhibitor
WO2005018653A1 (en) Oral skin care composition
TWI743747B (en) External agent for hair growth and growth

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20211110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220215

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20220215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220331

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230214

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230417

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230615

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230912

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231012

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231109

R150 Certificate of patent or registration of utility model

Ref document number: 7388748

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150